Rhodomycin A
Rhodomycin A can suppress lung cancer cell progression via modulating Src-related pathways.?Rhodomycin A significantly suppressed cancer cell proliferation, migration, invasion, and clonogenicity in vitro and tumour growth in vivo[1].
Product Specifications
CAS Number
23666-50-4
UNSPSC
12352005
Target
Src
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
CN(C)[C@H]([C@@H]([C@@H](O1)C)O)C[C@@H]1O[C@@H](C[C@]2(O)CC)C(C(O)=C3C(C(C4=CC=CC(O)=C4C3=O)=O)=C5O)=C5[C@H]2O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)N(C)C
Molecular Formula
C36H48N2O12
Molecular Weight
700.77
References & Citations
[1]Yi-Hua Lai, et al. Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways. Oncotarget. 2015 Sep 22;6 (28) :26252-65.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
